Integra LifeSciences Holdings Revenue 2010-2023 | IART

Integra LifeSciences Holdings revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Integra LifeSciences Holdings Annual Revenue
(Millions of US $)
2023 $1,542
2022 $1,558
2021 $1,542
2020 $1,372
2019 $1,518
2018 $1,472
2017 $1,188
2016 $992
2015 $883
2014 $797
2013 $697
2012 $831
2011 $780
2010 $732
2009 $682
Integra LifeSciences Holdings Quarterly Revenue
(Millions of US $)
2023-12-31 $397
2023-09-30 $382
2023-06-30 $381
2023-03-31 $381
2022-12-31 $398
2022-09-30 $385
2022-06-30 $398
2022-03-31 $377
2021-12-31 $406
2021-09-30 $387
2021-06-30 $390
2021-03-31 $360
2020-12-31 $389
2020-09-30 $370
2020-06-30 $259
2020-03-31 $354
2019-12-31 $395
2019-09-30 $379
2019-06-30 $384
2019-03-31 $360
2018-12-31 $383
2018-09-30 $366
2018-06-30 $366
2018-03-31 $357
2017-12-31 $369
2017-09-30 $279
2017-06-30 $282
2017-03-31 $259
2016-12-31 $256
2016-09-30 $250
2016-06-30 $249
2016-03-31 $237
2015-12-31 $241
2015-09-30 $226
2015-06-30 $213
2015-03-31 $203
2014-12-31 $153
2014-09-30 $198
2014-06-30 $231
2014-03-31 $215
2013-12-31 $81
2013-09-30 $213
2013-06-30 $206
2013-03-31 $197
2012-12-31 $214
2012-09-30 $210
2012-06-30 $210
2012-03-31 $196
2011-12-31 $204
2011-09-30 $202
2011-06-30 $193
2011-03-31 $181
2010-12-31 $194
2010-09-30 $187
2010-06-30 $179
2010-03-31 $173
2009-12-31 $184
2009-09-30 $172
2009-06-30 $166
2009-03-31 $161
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.228B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.951B 26.53
Intuitive Surgical (ISRG) United States $133.132B 80.20
Edwards Lifesciences (EW) United States $52.025B 33.89
DexCom (DXCM) United States $49.242B 74.90
IQVIA Holdings (IQV) United States $42.631B 25.28
IDEXX Laboratories (IDXX) United States $41.469B 49.58
Alcon (ALC) Switzerland $38.841B 28.64
STERIS (STE) Ireland $20.148B 23.85
Waters (WAT) United States $18.463B 26.49
Hologic (HOLX) United States $17.835B 19.68
SONOVA HOLDING (SONVY) Switzerland $16.800B 0.00
ShockWave Medical (SWAV) United States $12.341B 85.27
Fresenius Medical Care AG KGaA (FMS) Germany $11.795B 14.57
Sysmex ADR (SSMXY) Japan $10.000B 31.36
Teleflex (TFX) United States $9.736B 15.29
Penumbra (PEN) United States $7.923B 97.80
Masimo (MASI) United States $7.204B 40.40
Globus Medical (GMED) United States $6.843B 21.70
Glaukos (GKOS) United States $4.993B 0.00
Integer Holdings (ITGR) United States $3.671B 22.18
TransMedics (TMDX) United States $3.012B 0.00
LivaNova (LIVN) United Kingdom $2.996B 19.76
PROCEPT BioRobotics (PRCT) United States $2.664B 0.00
Elekta AB (EKTAY) Sweden $2.629B 18.04
Nihon Kohden (NHNKY) Japan $2.417B 20.44
Tandem Diabetes Care (TNDM) United States $2.275B 0.00
Inari Medical (NARI) United States $2.227B 384.20
RxSight (RXST) United States $1.952B 0.00
Alphatec Holdings (ATEC) United States $1.716B 0.00
Veracyte (VCYT) United States $1.450B 0.00
OPKO Health (OPK) United States $0.878B 0.00
Artivion (AORT) United States $0.847B 97.95
AVANOS MEDICAL, INC (AVNS) United States $0.836B 15.47
Paragon 28 (FNA) United States $0.730B 0.00
OrthoPediatrics (KIDS) United States $0.720B 0.00
Silk Road Medical (SILK) United States $0.697B 0.00
Treace Medical Concepts (TMCI) United States $0.642B 0.00
SiBone (SIBN) United States $0.598B 0.00
Mesa Laboratories (MLAB) United States $0.557B 18.90
IRadimed (IRMD) United States $0.530B 30.78
ORTHOFIX MEDICAL INC (OFIX) United States $0.486B 0.00
Nevro (NVRO) United States $0.415B 0.00
Pulse Biosciences (PLSE) United States $0.397B 0.00
Pacific Biosciences Of California (PACB) United States $0.394B 0.00
NeuroPace (NPCE) United States $0.385B 0.00
Tactile Systems Technology (TCMD) United States $0.340B 11.44
CVRx (CVRX) United States $0.317B 0.00
AxoGen (AXGN) United States $0.290B 0.00
EDAP TMS S.A (EDAP) France $0.270B 0.00
Sight Sciences (SGHT) United States $0.262B 0.00
AngioDynamics (ANGO) United States $0.233B 0.00
Accuray (ARAY) United States $0.217B 0.00
Atossa Genetics (ATOS) United States $0.192B 0.00
908 Devices (MASS) United States $0.187B 0.00
Semler Scientific (SMLR) United States $0.184B 9.89
Alpha Tau Medical (DRTS) Israel $0.168B 0.00
Inogen (INGN) United States $0.160B 0.00
ClearPoint Neuro (CLPT) United States $0.142B 0.00
Delcath Systems (DCTH) United States $0.135B 0.00
Neuronetics (STIM) United States $0.105B 0.00
Envoy Medical (COCH) United States $0.102B 0.00
KORU Medical Systems (KRMD) United States $0.100B 0.00
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
EnVVeno Medical (NVNO) United States $0.069B 0.00
Autonomix Medical (AMIX) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
SEP Acquisition (SEPA) United States $0.058B 0.00
Sensus Healthcare (SRTS) United States $0.056B 113.67
Vasomedical (VASO) United States $0.053B 9.47
Vicarious Surgical (RBOT) United States $0.047B 0.00
InspireMD (NSPR) Israel $0.047B 0.00
DarioHealth (DRIO) United States $0.044B 0.00
Aspira Women's Health (AWH) United States $0.041B 0.00
ReWalk Robotics (LFWD) Israel $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
LENSAR (LNSR) United States $0.037B 0.00
Pixie Dust Technologies (PXDT) Japan $0.037B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Lucid Diagnostics (LUCD) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
PAVmed (PAVM) United States $0.016B 0.00
T2 Biosystems (TTOO) United States $0.016B 0.00
Biosig Technologies (BSGM) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00